KAEX is a patent pending nutraceutical / otc pharmaceutical
Kaex has raised $3.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2026.
Kaex is headquartered in Zürich, Switzerland.
KAEX is a patent pending nutraceutical / otc pharmaceutical
Kaex is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kaex — Funding & Investors." VCBacked, February 19, 2026, https://www.vcbacked.co/company/kaex. Accessed July 28, 2026.
VCBacked. (2026). Kaex — Funding & Investors. Retrieved July 28, 2026, from https://www.vcbacked.co/company/kaex
{{cite web |title=Kaex — Funding & Investors |url=https://www.vcbacked.co/company/kaex |website=VCBacked |access-date=July 28, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated